Sama, A.D., Natrajan, S.D., D, P.D., Ramanathan, M.D., Ganesan, G.D., Susheelkumar, A.D., Kishore, B.D.N., Amir, A., & Kanmani, S.D. (2026). Combined Enhanced External Counterpulsation and Hyperbaric Oxygen Therapy in Ischemic Cardiomyopathy: Interim Results of a Prospective Study.. Journal of cardiac failure.
Sama AD, Natrajan SD, D PD, Ramanathan MD, Ganesan GD, Susheelkumar AD, et al. Combined Enhanced External Counterpulsation and Hyperbaric Oxygen Therapy in Ischemic Cardiomyopathy: Interim Results of a Prospective Study.. Journal of cardiac failure. 2026; PMID: 42102952
Sama AD, Natrajan SD, D PD, et al. Combined Enhanced External Counterpulsation and Hyperbaric Oxygen Therapy in Ischemic Cardiomyopathy: Interim Results of a Prospective Study.[J]. Journal of cardiac failure. 2026.
@article{sama2026,
author = {Akber Dr Sama and Sivakadaksham Dr Natrajan and Prabhakaran Dr D and Muthiaya Dr Ramanathan and Ganavelu Dr Ganesan and Alfred Dr Susheelkumar and Baskar Dr Naveen Kishore and Ali Amir and Srinivasan Dr Kanmani},
title = {Combined Enhanced External Counterpulsation and Hyperbaric Oxygen Therapy in Ischemic Cardiomyopathy: Interim Results of a Prospective Study.},
journal = {Journal of cardiac failure},
year = {2026},
note = {PMID: 42102952},
}
TY - JOUR AU - Akber Dr Sama AU - Sivakadaksham Dr Natrajan AU - Prabhakaran Dr D AU - Muthiaya Dr Ramanathan AU - Ganavelu Dr Ganesan AU - Alfred Dr Susheelkumar AU - Baskar Dr Naveen Kishore AU - Ali Amir AU - Srinivasan Dr Kanmani TI - Combined Enhanced External Counterpulsation and Hyperbaric Oxygen Therapy in Ischemic Cardiomyopathy: Interim Results of a Prospective Study. T2 - Journal of cardiac failure PY - 2026 AN - PMID:42102952 ER -
Ischemic cardiomyopathy remains a major contributor to chronic heart failure despite optimal guideline-directed medical therapy (GDMT). HEAT HF (HBOT and EECP as Adjuvant Therapy in Heart Failure) is the first prospective study to investigate the effect of Enhanced External Counterpulsation (EECP) with adjunctive Hyperbaric Oxygen Therapy (HBOT) on enhancing cardiac function and improving clinical outcomes in patients with ischemic cardiomyopathy.